Management of post-partum haemorrhage

Acta Anaesthesiologica Scandinavica

Volumn 54, Issue 10, 2010, Pages 1164-1178

  Ahonen, J ^a   Stefanovic, V ^a   Lassila, R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; CARBOPROST; DESMOPRESSIN; ERGOT ALKALOID; FIBRINOGEN; GLYCERYL TRINITRATE; HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLERGOMETRINE; MISOPROSTOL; OXYTOCIN; PLASMINOGEN; PROSTAGLANDIN; PROTEIN C; PROTEIN S; SULPROSTONE; TRANEXAMIC ACID;

ARTICLE; ARTIFICIAL EMBOLISM; BLEEDING DISORDER; BLOOD CLOTTING; BLOOD TRANSFUSION; CESAREAN SECTION; COMPRESSION GARMENT; EMERGENCY SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMOPHILIA A; HEMOPHILIA B; HUMAN; HYPERCOAGULABILITY; HYSTERECTOMY; PARTIAL THROMBOPLASTIN TIME; PERINEUM INJURY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROTHROMBIN TIME; REPEATED DRUG DOSE; RESUSCITATION; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UTERINE ATONY; VAGINAL DELIVERY; VENOUS THROMBOEMBOLISM; VON WILLEBRAND DISEASE;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD VOLUME; EMBOLIZATION, THERAPEUTIC; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOGEN; FIBRINOLYSIS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; OPERATIVE BLOOD SALVAGE; PLATELET TRANSFUSION; POSTPARTUM HEMORRHAGE; PREGNANCY; RESUSCITATION; UTERINE INERTIA; UTERUS; VON WILLEBRAND DISEASES;

EID: 78650197953     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02309.x     Document Type: Article

References (89)

1. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle M-H, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009;9:55.
2. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a populationbased study. J Matern Fetal Neonatal Med 2005;18:149-54.
3. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69-76.
4. Rouse DJ, Leindecker S, Landon M, Bloom SL, Varner MW, Moawad AH, Spong CY, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, O'Sullivan MJ, Sibai BM, Langer O. The MFMU cesarean registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol 2005;193:1056-60.
5. Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Acta Anaesthesiol Scand 2007;51:929-36.
6. Haynes K, Stone C, King J. Major morbidities associated with childbirth in Victoria: obstetric haemorrhage and associated hysterectomy. Public Heath Group, Department of Human Services, Melbourne, 2004. Available at http://www.health.vic.gov. au/maternitycare/(accessed 12 July 2010).
7. Whiteman MK, Kuklina E, Hillis SD, Jamieson DJ, Meikle SF, Posner SF, Marchbanks PA. Incidence and determinants of peripartum hysterectomy. Obstet Gynecol 2006;108:1486-92.
8. Mousa HA, Walkinshaw S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001;13:595-603.
9. Macphail S, Talks K. Massive post-partum haemorrhage and management of disseminated intravascular coagulation. Curr Obstet Gynaecol 2004;14:123-31.
10. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003;29:125-30.
11. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17:385-96.
12. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Isobel D, Walker D. Activated protein C sensitivity, protein C, protein S, and coagulation in normal pregnancy. Thromb Haemost 1998;79:1166-70.
13. Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, Jacquemyn Y, Van der Planken M. Haemostatic changes and acquired activated protein C resistance in normal pregnancy. Blood Coagul Fibrinolysis 2007;18:685-8.
14. Sainio S, Kekomäki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000;79:744-9.
15. Higgins JR, Walshe JJ, Darling MRN, Norris L, Bonnar J. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol 1998;179:520-6.
16. Epiney M, Boehlen F, Boulvain M, Reber G, Antonelli E, Morales M, Irion O, De Moerloose P. D-dimer levels during delivery and the postpartum. J Thromb Haemost 2005;3:268-71.
17. Ghirardini G, Battioni M, Bertellini C, Colombini R, Colla R, Rossi G. D-dimer after delivery in uncomplicated pregnancies. Clin Exp Obstet Gynecol 1999;26:211-2.
18. Wojciechowski PJ, Samol N, Walker J. Coagulopathy in massive transfusion. Int Anesthesiol Clin 2005;43:1-20.
19. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multicenter, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004;112:154-7.
20. Mayur G, Purvi P, Ashoo G, Pankaj D. Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study. J Obstet Gynecol India 2007;57:227-30.
21. Yang H, Zheng S, Shi C. Clinical study on the efficacy of tranexamic acid in reducing postpartum blood loss: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi 2001;36:590-2.
22. Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in postpartum haemorrhage: a systematic review. BMC Pregnancy and Childbirth 2009;9:29-34.
23. Chandraharan E, Arulkumaran S. Surgical aspects of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008;22:1089-102.
24. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. Br Med J 2001;322:1089-94.
25. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, De Prost D. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thrombost Haemost 2007;5:266-73.
26. Scottish Confidential Audit of Severe Maternal Morbidity. 5th Annual Report 2007. Reproductive Health Programme, NHS QIS.
27. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009;22:267-74.
28. Kozek-Langenecker S. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-60.
29. Westphal M, James MFM, Kozek-Langenecker S, Stocker R, Guidet P, Van Aken H. Hydroxyethyl starches. Anesthesiology 2009;111:187-202.
30. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 2007;105:905-17.
31. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Innerhofer P. Effect of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 2008;100:307-14.
32. Karpati PCJ, Rossignol M, Pirot M, Cholley B, Vicaut E, Henry P, Kévorkian J-P, Schurando P, Peynet J, Jacob D, Payen D, Mebazaa A. High incidence of myocardial ischemia during postpartum hemorrhage. Anesthesiology 2004;100:30-6.
33. Erber WN. Massive blood transfusion in the elective surgical setting. Transfus Apheresis Sci 2002;27:83-92.
34. Thachil J, Toh C-H. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev 2009;23:167-76.
35. Simon L, Santi TL, Sacquin P, Hamza J. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. Br J Anaesth 1997;78:678-83.
36. ®: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005;49:222-31.
37. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz R-C. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009;116:1097-102.
38. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007;63:805-13.
39. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Béguin S, Hemker HC. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002;88:576-82.
40. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 2006;26:41-8.
41. Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2004;2:402-13.
42. Hsieh L, Nugent D. Factor XIII deficiency. Haemophilia 2008;14:1190-200.
43. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, Schnider T, Korte W. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004;99:1564-9.
44. Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity. Implications of a prospective study. Stroke 2002;33:1618-23.
45. Moscardo F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001;113:174-6.
46. Ahonen J, Jokela R. Recombinant factor VIIa for lifethreatening post-partum haemorrhage. Br J Anaesth 2005;94:592-5.
47. Alfirevic Z, Elbourne D, Pavord S, Bolte A, van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EB, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G. Use of recombinant activated factor VII in primary postpartum hemorrhage. Obstet Gynecol 2007;110:1270-8.
48. Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand haemostasis registry. Anesth Analg 2009;109:1908-15.
49. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008;48:12-6.
50. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth 2007;16:40-9. (Pubitemid 44909444)
51. Glynn JC, Plaat F. Prothrombin complex for massive obstetric haemorrhage. Anaesthesia 2007;62:202-3.
52. Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 2007;82:731-5.
53. Kirkpatrick AW, Chun R, Brown R, Simons RK. Hypothermia and the trauma patient. Can J Surg 1999;42:333-43.
54. Meng ZH, Wolberg AS, Monroe DM, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003;55:886-91.
55. Rare bleeding disorder database. Available at http://www.rbdd.org/ (accessed 12 July 2010).
56. Chi C, Lee CA, Shiltagh N, Khan A, Pollard D, Kadir RA. Pregnancy in carriers of haemophilia. Haemophilia 2008;14:56-64.
57. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anaesth 2008;17:37-45.
58. Sullivan I, Faulds J, Ralph C. Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective caesarean section. Br J Anaesth 2008;101:225-9.
59. Vercauteren M, Palit Ş, Soetens F, Jacquemyn Y, Alahuhta S. Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiol Scand 2009;53:701-9.
60. McCandlish R, Bowler U, Van Asten H, Berridge G, Winter C, Sames L, Garcia J, Renfrew M, Elbourne D. A randomised controlled trial of care of the perineum during second stage of normal labour. Br J Obstet Gynaecol 1998;105:1262-72.
61. Doumouchtsis SK, Papageorghiou AT, Vernier C, Arulkumaran S. Management of postpartum hemorrhage by uterine balloon tamponade: prospective evaluation of effectiveness. Acta Obstet Gynecol 2008;87:849-55.
62. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Br J Obstet Gynaecol 1997;104:372-5.
63. Cho JH, Jun. HS, Lee CN. Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstet Gynecol 2000;96:129-31.
64. Tamizian O, Arulkumaran S. The surgical management of postpartum haemorrhage. Curr Opin Obstet Cynecol 2001;13:127-31.
65. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systemic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007;62:540-7.
66. Hidar S, Jennane TM, Bouguizane S, Lassoued L, Bibi M, Khairi H. The effect of placental removal method at cesarean delivery on perioperative hemorrhage: a randomized clinical trial ISRCTN 49779257. Eur J Obstet Gynecol Reprod Biol 2004;117:179-82.
67. Deneux-Tharaux C, Macfarlane A, Winter C, Zhang W-H, Alexander S, Bouvier-Colle M-Hthe EUPHRATES Group. Policies for manual removal of placenta at vaginal delivery: variations in timing within Europe. BJOG 2009;116:119-24.
68. National Collaborating Centre for Women's and Children's Health (NCCWCH). Intrapartum care. Care of healthy women and their babies during childbirth. London: RCOG Press, 2007.
69. WHO. Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice, 2nd edn. Geneva: WHO, 2006: B11pp.
70. Combs CA, Laros RK. Prolonged third stage of labour: morbidity and risk factors. Obstet Gynecol 1991;77:863-7.
71. Bider D, Dulitzky M, Goldenberg M, Lipitz S, Mashiach S. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta. Eur J Obstet Gynecol Reprod Biol 1996;64:59-61.
72. Weeks AD. Retained placenta. Best Pract Res Clin Obstet Gynaecol 2008;22:1103-17.
73. Bullarbo M, Tjugum J, Ekerhovd E. Sublingual nitroglycerin for management of retained placenta. Int J Gynaecol Obstet 2005;91:228-32.
74. van Beekhuizen HJ, de Groot ANJA, De Boo T, Burger D, Jansen N, Lotgering FK. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol 2006;194:446-50.
75. Weeks A, Alia G, Vernon G, Namayanja A, Gosakan R, Majeed T, Hart A, Jafri H, Nardin J, Carroli G, Fairlie F, Raashid Y, Mirembe F, Alfirevic Z. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomized controlled trial. Lancet 2010;375:141-7.
76. Flood KM, Said S, Geary M, Robson M, Fitzpatrick C, Malone FD. Changing trends in peripartum hysterectomy over the last 4 decades. Am J Obstet Gynecol 2009;200:632. e1-6.
77. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009;116:648-54.
78. Shrivastava V, Nageotte M, Major C, Haydon M, Wing D. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007;197: e1-5.
79. Ojala K, Perala J, Kariniemi J, Ranta P, Raudaskoski T, Tekay A. Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 2005;84:1075-80.
80. O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632-8.
81. Luo G, Perni SC, Jean-Pierre C, Baergen RN, Predanic M. Failure of conservative management of placenta previapercreta. J Perinat Med 2005;33:564-8.
82. Winograd RH. Uterine artery embolization for postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008;22:1119-32.
83. Touboul C, Badiou W, Saada J, Pelage J-P, Payen D, Vicaut E, Jacob D, Rafii A. Efficacy of selective arterial embolisation for the treatment of life-threatening postpartum haemorrhage in a large population. Plos One 2008;3: e3819.
84. Ledee N, Ville Y, Musset D, Mercier F, Frydman R, Fernandez H. Management in intractable obstetric haemorrhage: an audit study of 61 cases. Eur J Obstet Gynecol Reprod Biol 2001;94:189-96.
85. Eriksson L-G, Mulic-Lutvica A, Jangland L, Nyman R. Massive postpartum hemorrhage treated with transcatheter arterial embolization: technical aspects and long-term effects on fertility and menstrual cycle. Acta Radiol 2007;48:635-42.
86. Maassen MS, Lambers MDA, Tutein Nolthenius RP, van der Valk PHM, Elgersma OE. Complications and failure of uterine artery embolisation for intractable postpartum haemorrhage. BJOG 2009;116:55-61.
87. Gershon AS, Faughnan ME, Chon KS, Pugash RA, Clark JA, Bohan MJ, Henderson KJ, Hyland RH, White RI Jr. Transcatheter embolotherapy of maternal pulmonary arteriovenous malformations during pregnancy. Chest 2001;119:470-7.
88. Nikolic B, Spies JB, Lundsten MJ, Abbara S. Patient radiation dose associated with uterine artery embolization. Radiology 2000;214:121-5.
89. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003;17: S1-5.